Antiherpetic mode of action of (22S,23S)-3β-bromo-5α,22,23- trihydroxystigmastan-6-one in vitro
The replication of herpes simplex virus (HSV) type 1 in Vero cells is inhibited in the presence of (22S,23S)-3β-bromo-5α,22,23- trihydroxystigmastan-6-one (6b), a synthetic brassinosteroid derivative. Attempts to disclose the mode of action of 6b indicate that a late step of virus multiplication is...
Guardado en:
Autores principales: | , , , , |
---|---|
Publicado: |
2004
|
Materias: | |
Acceso en línea: | https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_09248579_v23_n5_p524_Wachsman http://hdl.handle.net/20.500.12110/paper_09248579_v23_n5_p524_Wachsman |
Aporte de: |
id |
paper:paper_09248579_v23_n5_p524_Wachsman |
---|---|
record_format |
dspace |
spelling |
paper:paper_09248579_v23_n5_p524_Wachsman2023-06-08T15:51:10Z Antiherpetic mode of action of (22S,23S)-3β-bromo-5α,22,23- trihydroxystigmastan-6-one in vitro Wachsman, Mónica Beatriz Castilla, Viviana Talarico, Laura Beatriz Ramirez, Javier Alberto Coto, Celia Esther (22S,23S)-3β- Bromo-5α,22,23-trihydroxystigmastan-6-one Antiviral Brassinosteroid derivatives Herpes simplex 3beta bromo 5alpha,22,23 trihydroxystigmastan 6 one antivirus agent brassinosteroid unclassified drug animal cell antigen expression article controlled study drug mechanism Herpes simplex virus 1 immunofluorescence test in vitro study nonhuman priority journal protein synthesis Vero cell virus replication Animals Antigens, Viral Antiviral Agents Cercopithecus aethiops Cholestanones Fluorescent Antibody Technique, Indirect Herpesvirus 1, Human Transcription, Genetic Vero Cells Viral Proteins Virus Replication The replication of herpes simplex virus (HSV) type 1 in Vero cells is inhibited in the presence of (22S,23S)-3β-bromo-5α,22,23- trihydroxystigmastan-6-one (6b), a synthetic brassinosteroid derivative. Attempts to disclose the mode of action of 6b indicate that a late step of virus multiplication is affected. In the presence of 6b, HSV late protein synthesis was severely diminished and this inhibitory effect of 6b on HSV antigen expression was confirmed by immunofluorescence assays. © 2004 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved. Fil:Wachsman, M.B. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Castilla, V. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Talarico, L.B. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Ramirez, J.A. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Coto, C.E. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. 2004 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_09248579_v23_n5_p524_Wachsman http://hdl.handle.net/20.500.12110/paper_09248579_v23_n5_p524_Wachsman |
institution |
Universidad de Buenos Aires |
institution_str |
I-28 |
repository_str |
R-134 |
collection |
Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) |
topic |
(22S,23S)-3β- Bromo-5α,22,23-trihydroxystigmastan-6-one Antiviral Brassinosteroid derivatives Herpes simplex 3beta bromo 5alpha,22,23 trihydroxystigmastan 6 one antivirus agent brassinosteroid unclassified drug animal cell antigen expression article controlled study drug mechanism Herpes simplex virus 1 immunofluorescence test in vitro study nonhuman priority journal protein synthesis Vero cell virus replication Animals Antigens, Viral Antiviral Agents Cercopithecus aethiops Cholestanones Fluorescent Antibody Technique, Indirect Herpesvirus 1, Human Transcription, Genetic Vero Cells Viral Proteins Virus Replication |
spellingShingle |
(22S,23S)-3β- Bromo-5α,22,23-trihydroxystigmastan-6-one Antiviral Brassinosteroid derivatives Herpes simplex 3beta bromo 5alpha,22,23 trihydroxystigmastan 6 one antivirus agent brassinosteroid unclassified drug animal cell antigen expression article controlled study drug mechanism Herpes simplex virus 1 immunofluorescence test in vitro study nonhuman priority journal protein synthesis Vero cell virus replication Animals Antigens, Viral Antiviral Agents Cercopithecus aethiops Cholestanones Fluorescent Antibody Technique, Indirect Herpesvirus 1, Human Transcription, Genetic Vero Cells Viral Proteins Virus Replication Wachsman, Mónica Beatriz Castilla, Viviana Talarico, Laura Beatriz Ramirez, Javier Alberto Coto, Celia Esther Antiherpetic mode of action of (22S,23S)-3β-bromo-5α,22,23- trihydroxystigmastan-6-one in vitro |
topic_facet |
(22S,23S)-3β- Bromo-5α,22,23-trihydroxystigmastan-6-one Antiviral Brassinosteroid derivatives Herpes simplex 3beta bromo 5alpha,22,23 trihydroxystigmastan 6 one antivirus agent brassinosteroid unclassified drug animal cell antigen expression article controlled study drug mechanism Herpes simplex virus 1 immunofluorescence test in vitro study nonhuman priority journal protein synthesis Vero cell virus replication Animals Antigens, Viral Antiviral Agents Cercopithecus aethiops Cholestanones Fluorescent Antibody Technique, Indirect Herpesvirus 1, Human Transcription, Genetic Vero Cells Viral Proteins Virus Replication |
description |
The replication of herpes simplex virus (HSV) type 1 in Vero cells is inhibited in the presence of (22S,23S)-3β-bromo-5α,22,23- trihydroxystigmastan-6-one (6b), a synthetic brassinosteroid derivative. Attempts to disclose the mode of action of 6b indicate that a late step of virus multiplication is affected. In the presence of 6b, HSV late protein synthesis was severely diminished and this inhibitory effect of 6b on HSV antigen expression was confirmed by immunofluorescence assays. © 2004 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved. |
author |
Wachsman, Mónica Beatriz Castilla, Viviana Talarico, Laura Beatriz Ramirez, Javier Alberto Coto, Celia Esther |
author_facet |
Wachsman, Mónica Beatriz Castilla, Viviana Talarico, Laura Beatriz Ramirez, Javier Alberto Coto, Celia Esther |
author_sort |
Wachsman, Mónica Beatriz |
title |
Antiherpetic mode of action of (22S,23S)-3β-bromo-5α,22,23- trihydroxystigmastan-6-one in vitro |
title_short |
Antiherpetic mode of action of (22S,23S)-3β-bromo-5α,22,23- trihydroxystigmastan-6-one in vitro |
title_full |
Antiherpetic mode of action of (22S,23S)-3β-bromo-5α,22,23- trihydroxystigmastan-6-one in vitro |
title_fullStr |
Antiherpetic mode of action of (22S,23S)-3β-bromo-5α,22,23- trihydroxystigmastan-6-one in vitro |
title_full_unstemmed |
Antiherpetic mode of action of (22S,23S)-3β-bromo-5α,22,23- trihydroxystigmastan-6-one in vitro |
title_sort |
antiherpetic mode of action of (22s,23s)-3β-bromo-5α,22,23- trihydroxystigmastan-6-one in vitro |
publishDate |
2004 |
url |
https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_09248579_v23_n5_p524_Wachsman http://hdl.handle.net/20.500.12110/paper_09248579_v23_n5_p524_Wachsman |
work_keys_str_mv |
AT wachsmanmonicabeatriz antiherpeticmodeofactionof22s23s3bbromo5a2223trihydroxystigmastan6oneinvitro AT castillaviviana antiherpeticmodeofactionof22s23s3bbromo5a2223trihydroxystigmastan6oneinvitro AT talaricolaurabeatriz antiherpeticmodeofactionof22s23s3bbromo5a2223trihydroxystigmastan6oneinvitro AT ramirezjavieralberto antiherpeticmodeofactionof22s23s3bbromo5a2223trihydroxystigmastan6oneinvitro AT cotoceliaesther antiherpeticmodeofactionof22s23s3bbromo5a2223trihydroxystigmastan6oneinvitro |
_version_ |
1768544601797296128 |